Molecular Targeted Therapy Market to Surpass $246 Billion by 2034 | Exactitude Consultancy

A new report from Exactitude Consultancy predicts that the molecular targeted therapy market will surpass $246 billion by 2034, marking significant growth in the healthcare sector.